Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Seven Oxford scientists are amongst 48 of the UK's world-leading researchers elected to join the prestigious Fellowship of the Academy of Medical Sciences this year.

The new Fellows have been elected for their outstanding contributions to biomedical and health science, leading research discoveries, and translating developments into benefits for patients and the wider society. 

The new Fellows, all from the Medical Sciences Division are:

Professor Susan Jebb OBE, Professor of Diet and Population Health, University of Oxford

Professor Eleanor Barnes, Professor of Hepatology and Experimental Medicine, University of Oxford.

Professor David Beeson, Professor in Molecular Neuroscience, University of Oxford. 

Professor Robert MacLaren, Professor of Ophthalmology, University of Oxford. 

Professor Jordan Raff, César Milstein Professor of Cancer Cell Biology, University of Oxford.

Professor Guy Thwaites, Professor of Infectious Diseases, University of Oxford and Director, Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Research Program in Vietnam.

Professor Mark Woodward, Professor of Epidemiology and Statistics, University of Oxford

Congratulations to all Fellows!

Find out more (University of Oxford website)

Similar stories

Major grant to strengthen research and benefit patients

Oxford University Hospitals (OUH) has made a grant of £11.5 million to the University of Oxford, which the University will match with other funding, to allow the development of major clinical research facilities which have the potential to support the introduction of innovative and ground-breaking treatments for patients.

Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology

Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.

Oxford joins forces with 11 universities to launch social impact investment fund

The University of Oxford has joined forces with 11 leading universities to create Impact 12, an impact investment fund to support mission-led university ventures.

Ivermectin to be investigated as a possible treatment for COVID-19 in the PRINCIPLE trial

From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.